A Randomized, Controlled Trial of Yoga in Pediatric Inflammatory Bowel Disease: Preliminary Findings

P573 A Randomized, Controlled Trial of Yoga in Pediatric Inflammatory Bowel Disease: Preliminary Findings Alycia Leiby, MD Author Insight from Alycia Leiby, MD, Pediatric Gastroenterology, Goryeb Children’s Hospital Atlantic Health System, ...

Updated Incidence and Prevalence of Crohn’s Disease and Ulcerative Colitis in Olmsted County, Minnesota (between 1970 and 2010)

Plenary Session 1: IBD / Small Intestine / Unclassified Wednesday, October 22 8:30 am – 10:15 am Moderators: Francis A. Farraye, MD, MSc, FACG Jonathan A. Leighton MD, FACG Oral 59: Updated Incidence and Prevalence of Crohn’s Disease and ...

Health Outcomes of Ulcerative Colitis (UC) and Crohn’s Disease (CD) Patients Hospitalized With Human Cytomegalovirus (CMV) Disease

Plenary Session 1: IBD / Small Intestine / Unclassified Wednesday, October 22 8:30 am – 10:15 am Moderators: Francis A. Farraye, MD, MSc, FACG Jonathan A. Leighton MD, FACG Oral 62: Health Outcomes of Ulcerative Colitis (UC) and Crohn’s ...

Pediatric Crohn’s Disease, Unrealized Height and Diminished Lifetime Earnings

P1654 Pediatric Crohn’s Disease, Unrealized Height and Diminished Lifetime Earnings Russell D. Cohen, MD, FACG Author insight from Russell D. Cohen, MD, FACG, University of Chicago, Chicago, IL What’s new here and important for clinicians? This ...

Does End-to-End Versus Side-to-Side Anastomosis in Postoperative Crohn’s Disease Matter? Prospective 2-Year Evaluation of Postoperative Quality of Life, Health Care Utilization, and Clinical Activity

Plenary Session 2: IBD Monday, October 20 2:15 pm – 3:00 pm MODERATORS:    Uma Mahadevan, MD, FACG Sunanda V. Kane, MD, MSPH, FACG Oral 17: Does End-to-End Versus Side-to-Side Anastomosis in Postoperative Crohn’s Disease Matter? Prospective ...

Choosing and Monitoring Biologic Therapy for IBD

David T. Rubin, MD, FACG Simultaneous Symposia 1a: Choosing and Monitoring Biologic Therapy for IBD Monday, October 20 11:30 am – 12:45 pm Moderator: David T. Rubin, MD, FACG Positioning Biologics in Ulcerative Colitis Bruce E. Sands, MD, ...